m-RESIST: The vision which became a reality! | ATC innovation Lab
Back to Top

m-RESIST: The vision which became a reality!

16 February 2018

The m-RESIST Final Review will be held on February 20, 2018, at the EC premises in Brussels, to validate project results and achievements. This three-year project (2015- 2017), of more than 3 million euro, developed an innovative disease management system focused on the needs of patients with Treatment-Resistant Schizophrenia, studying new therapeutic protocols and disease management methods using mobile technologies.

The project m-RESIST: "Mobile Therapeutic Attention for Patients with Treatment Resistant” was funded by European Commission and coordinated by TICSALUT Foundation in Spain with the participation of 11 partners from 7 countries (Spain, Finland, Greece, Italy, Belgium, Hungary and Israel). Through this project, the following results have been delivered:

  • m-RESIST clinical Interventions for Treatment Resistant Schizophrenia
  • m-RESIST innovative clinical interventions for staff and professionals
  • m-RESIST innovative mHealth system

For more information, read the full Press Release here!